Prevalence of SARS-Cov-2 antibodies and living conditions: the French national random population-based EPICOV cohort. Josiane Warszawski,Anne-Lise Beaumont,Rémonie Seng,Xavier de Lamballerie,Delphine Rahib,Nathalie Lydié,Rémy Slama,Sylvain Durrleman,Philippe Raynaud,Patrick Sillard,François Beck,Laurence Meyer,Nathalie Bajos,and The EPICOV study group. . ; : Article
Épidémiologie clinique